Virtus ETF Advisers LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43,219
-65.9%
18,313
-9.1%
0.03%
-65.3%
Q2 2023$126,863
+92.9%
20,137
+76.7%
0.08%
+108.3%
Q1 2023$65,755
-59.4%
11,396
-27.8%
0.04%
-57.6%
Q4 2022$161,841
+24.5%
15,774
+102.9%
0.08%
+63.5%
Q3 2022$130,000
+20.4%
7,775
+0.8%
0.05%
+30.0%
Q2 2022$108,0007,7160.04%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders